DEFINING TOMORROW'S VASCULAR STRATEGIES
×
Register now to R3i !
Your login
Your password
Confirm your password
Your email
I agree to receive the R3i newsletter
R3i Global events
10 February 2023
Reducing Vascular Complications of Type 2 Diabetes:
New Targets, New Treatments
10 February 2023 - Reducing Vascular Complications of Type 2 Diabetes:<br>New Targets, New Treatments
The R3i International Steering Committee meeting, Marrakech 2023
Marrakech, Morroco
1 September 2019
Addressing residual vascular risk :
Is a new therapy on the horizon?
1 September 2019 - Addressing residual vascular risk :<br> Is a new therapy on the horizon?
R31 & IAS Press Conference
Paris, France
24 November 2018
The Selective Peroxisome Proliferator-Activated Receptor Alpha Modulator (SPPARMa) Concept
24 November 2018 - The Selective Peroxisome Proliferator-Activated Receptor Alpha Modulator (SPPARMa) Concept
New Joint Initiative of the International Atherosclerosis Society (IAS) and Residual Risk Reduction Initiative (R3i) on the concept of SPPARM-a
Chantilly, France
13 June 2018
Highlights from the Joint Satellite Symposium of the IAS and the International Chair on Cardiometabolic Risk
13 June 2018 - Highlights from the Joint Satellite Symposium of the IAS and the International Chair on Cardiometabolic Risk
IAS 2018 - XVIII International Symposium on Atherosclerosis
Toronto, Canada
26 August 2017
ESC 2017: New approaches to targeting residual cardiovascular risk
26 August 2017 - ESC 2017: New approaches to targeting residual cardiovascular risk
ESC Congress 2017
Barcelona, Spain
10 June 2017
MSDA 2017 - 12th Metabolic Syndrome, type II Diabetes and Atherosclerosis Congress
10 June 2017 - MSDA 2017 - 12th Metabolic Syndrome, type II Diabetes and Atherosclerosis Congress
MSDA 2017 - 12th Metabolic Syndrome, type II Diabetes and Atherosclerosis Congress
Saint Petersburg, Russia
26 May 2015
ISA 2015 Coverage
26 May 2015 -  ISA 2015 Coverage
The 17th International Symposium on Atherosclerosis
Amsterdam, The Nederlands
18 September 2014
Preventive cardiology R3i session
18 September 2014 - Preventive cardiology R3i session
PEDIM 2014 - Prague European Days of Internal Medicine
Prague, Czech Republic
12 September 2014
MSDA Kyoto 2014 - A highlight of R3i activities
12 September 2014 - MSDA Kyoto 2014 - A highlight of R3i activities
9th Metabolic syndrome, Type 2 Diabetes and Atherosclerosis Congress (MSDA 2014)
Kyoto, Japan
29 July 2014
CASMU R3i Symposium : Una actualización en dislipemias aterogénicas
29 July 2014 - CASMU R3i Symposium : Una actualización en dislipemias aterogénicas
La formación médica continua de la Escuela de Graduados, por encargo del Departamento de Cardiología de CASMU
Montevideo, Uruguay
22 March 2014
R3i Goes Global: Latin America launch at SOCESP
22 March 2014 - R3i Goes Global: Latin America launch at SOCESP
Sociedade de Cardiologia do Estado de Sao Paulo Congress (SOCESP 2014)
Sao Paulo, Brazil
4 October 2013
R3i symposium : Residual Risk – What does it mean? How to influence it?
4 October 2013 - R3i symposium : Residual Risk – What does it mean? How to influence it?
12th European Congress of Internal Medicine
Prague, Czech Republic